A candidate gene association study further corroborates involvement of contactin genes in autism

Molecular Syndromology

Volumn 5, Issue 5, 2014, Pages 229-235

  Poot, Martin ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autism; Candidate gene association study; CNTN5; CNTN6; CNTNAP2; Contactin gene family; Copy number variation

Indexed keywords

CONTACTIN; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; AUTISM; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE SEGREGATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; YOUNG ADULT;

EID: 84906874671     PISSN: 16618769     EISSN: 16618777     Source Type: Journal    
DOI: 10.1159/000362891     Document Type: Article

References (45)

1. Abrahams B, Geschwind DH: Advances in autism genetics: on the threshold of a new neurobiol-ogy. Nat Rev Genet 9: 341-355 (2008).
2. Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, et al: Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum Mol Genet 21: 4781-4792 (2012).
3. Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, et al: Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39: 319-328 (2007).
4. Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, et al: Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 5:e1000536 (2009).
5. Chilian B, Abdollahpour H, Bierhals T, Haltrich I, Fekete G, et al: Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin Genet 84: 560-565 (2013).
6. Curran S, Bolton P, Rozsnyai K, Chiocchetti A, Klauck SM, et al: No association between a common single nucleotide polymorphism, rs4141463, in the MACROD2 gene and autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 156B:633-639 (2011).
7. Endele S, Rosenberger G, Geider K, Popp B, Tamer C, et al: Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 42: 1021-1026 (2010).
8. Freitag CM: The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry 12: 2-22 (2007).
9. Girirajan S, Eichler EE: Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet 19:R176-R187 (2010).
10. Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, et al: Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 367: 1321-1331 (2012).
11. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, et al: Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459: 569-573 (2009).
12. Holt R, Barnby G, Maestrini E, Bacchelli E, Brock-lebank D, et al: Linkage and candidate gene studies of autism spectrum disorders in European populations. Eur J Hum Genet 18: 1013-1019 (2010).
13. Huguet G, Ey E, Bourgeron T: The genetic landscapes of autism spectrum disorders. Annu Rev Genomics Hum Genet 14: 191-213 (2013).
14. Klei L, Sanders SJ, Murtha MT, Hus V, Lowe JK, et al: Common genetic variants, acting addi-tively, are a major source of risk for autism. Mol Autism 3: 9 (2012).
15. Leblond CS, Heinrich J, Delorme R, Proepper C, Betancur C, et al: Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 8:e1002521 (2012).
16. Ma D, Salyakina D, Jaworski JM, Konidari I, Whitehead PL, et al: A genome-wide association study of autism reveals a common novel risk locus at 5p14.1. Ann Hum Genet 73: 263-273 (2009).
17. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, et al: Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82: 477-488 (2008).
18. Nava C, Keren B, Mignot C, Rastetter A, Chantot-Bastaraud S, et al: Prospective diagnostic analysis of copy number variants using SNP microarrays in individuals with autism spectrum disorders. Eur J Hum Genet 22: 71-78 (2014).
19. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, et al: Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485: 242-245 (2012).
20. Ogawa J, Lee S, Itoh K, Nagata S, Machida T, et al: Neural recognition molecule NB-2 of the con-tactin/F3 subgroup in rat: specificity in neu-rite outgrowth-promoting activity and restricted expression in the brain regions. J Neurosci Res 65: 100-110 (2001).
21. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, et al: Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43: 585-589 (2011).
22. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, et al: Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485: 246-250 (2012a).
23. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, et al: Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338: 1619-1622 (2012b).
24. Peñagarikano O, Geschwind DH: What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med 18: 156-163 (2012).
25. Peñagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, et al: Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147: 235-246 (2011).
26. Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB: Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet 9:e1003709 (2013).
27. Poot M: Towards identification of individual etiologies by resolving genomic and biological conundrums in patients with autism spectrum disorders. Mol Syndromol 4: 213-226 (2013).
28. Poot M, Eleveld MJ, van 't Slot R, Ploos van Am-stel HK, Hochstenbach R: Recurrent copy number changes in mentally retarded children harbour genes involved in cellular localization and the glutamate receptor complex. Eur J Hum Genet 18: 39-46 (2010a).
29. Poot M, Beyer V, Schwaab I, Damatova N, Van 't Slot R, et al: Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 11: 81-89 (2010b).
30. Poot M, van der Smagt JJ, Brilstra EH, Bourgeron T: Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia. Cyto-genet Genome Res 135: 228-240 (2011).
31. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al: LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337 (2010).
32. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575 (2007).
33. Rodenas-Cuadrado P, Ho J, Vernes SC: Shining a light on CNTNAP2: complex functions to complex disorders. Eur J Hum Genet 22: 171-178 (2014).
34. Salyakina D, Cukier HN, Lee JM, Sacharow S, Nations LD, et al: Copy number variants in extended autism spectrum disorder families reveal candidates potentially involved in autism risk. PLoS One 6:e26049 (2011).
35. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, et al: Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70: 863-885 (2011).
36. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, et al: De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485: 237-241 (2012).
37. Shimoda Y, Koseki F, Itoh M, Toyoshima M, Watanabe K: A cis-xcomplex of NB-2/contac-tin-5 with amyloid precursor-like protein 1 is localized on the presynaptic membrane. Neu-rosc Let 510: 148-153 (2012).
38. Skuse DH: Rethinking the nature of genetic vulnerability to autistic spectrum disorders. Trends Genet 23: 387-395 (2007).
39. State MW, Levitt P: The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci14: 1499-1506 (2011).
40. Stein MB, Yang BZ, Chavira DA, Hitchcock CA, Sung SC, et al: A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits. Biol Psychiatry 69: 825-831 (2011).
41. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, et al: Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 26: 363-372 (2010).
42. van Daalen E, Kemner C, Verbeek NE, van der Zwaag B, Dijkhuizen T, et al: Social Responsiveness Scale-aided analysis of the clinical impact of copy number variations in autism. Neurogenetics 12: 315-323 (2011).
43. Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, et al: A functional genetic link between distinct developmental language disorders. N Engl J Med 359: 2337-2345 (2008).
44. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, et al: Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459: 528-533 (2009).
45. Webber C: Functional enrichment analysis with structural variants: pitfalls and strategies. Cy-togenet Genome Res 135: 277-285 (2011).